全文获取类型
收费全文 | 13182篇 |
免费 | 1185篇 |
国内免费 | 733篇 |
专业分类
耳鼻咽喉 | 213篇 |
儿科学 | 211篇 |
妇产科学 | 169篇 |
基础医学 | 1788篇 |
口腔科学 | 117篇 |
临床医学 | 1666篇 |
内科学 | 2190篇 |
皮肤病学 | 143篇 |
神经病学 | 702篇 |
特种医学 | 449篇 |
外国民族医学 | 9篇 |
外科学 | 1337篇 |
综合类 | 1688篇 |
现状与发展 | 2篇 |
一般理论 | 1篇 |
预防医学 | 666篇 |
眼科学 | 371篇 |
药学 | 1313篇 |
14篇 | |
中国医学 | 632篇 |
肿瘤学 | 1419篇 |
出版年
2024年 | 27篇 |
2023年 | 215篇 |
2022年 | 513篇 |
2021年 | 635篇 |
2020年 | 483篇 |
2019年 | 484篇 |
2018年 | 463篇 |
2017年 | 391篇 |
2016年 | 398篇 |
2015年 | 617篇 |
2014年 | 766篇 |
2013年 | 710篇 |
2012年 | 969篇 |
2011年 | 1000篇 |
2010年 | 623篇 |
2009年 | 531篇 |
2008年 | 636篇 |
2007年 | 656篇 |
2006年 | 657篇 |
2005年 | 623篇 |
2004年 | 421篇 |
2003年 | 390篇 |
2002年 | 358篇 |
2001年 | 278篇 |
2000年 | 310篇 |
1999年 | 341篇 |
1998年 | 192篇 |
1997年 | 213篇 |
1996年 | 184篇 |
1995年 | 151篇 |
1994年 | 139篇 |
1993年 | 88篇 |
1992年 | 106篇 |
1991年 | 67篇 |
1990年 | 70篇 |
1989年 | 67篇 |
1988年 | 49篇 |
1987年 | 48篇 |
1986年 | 45篇 |
1985年 | 24篇 |
1984年 | 26篇 |
1983年 | 25篇 |
1982年 | 12篇 |
1981年 | 19篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 11篇 |
1976年 | 10篇 |
1974年 | 7篇 |
1971年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling 总被引:3,自引:0,他引:3
993.
Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray 总被引:12,自引:0,他引:12
Luo A Kong J Hu G Liew CC Xiong M Wang X Ji J Wang T Zhi H Wu M Liu Z 《Oncogene》2004,23(6):1291-1299
To identify genes that are differentially expressed in human esophageal squamous cell carcinoma (ESCC), we have developed a cDNA microarray representing 34 176 clones to analyse gene expression profiles in ESCC. A total of 77 genes (including 31 novel genes) were downregulated, and 15 genes (including one novel gene) were upregulated in cancer tissues compared with their normal counterparts. Immunohistochemistry and Northern blot analysis were carried out to verify the cDNA microarray results. It was revealed that genes involved in squamous cell differentiation were coordinately downregulated, including annexin I, small proline-rich proteins (SPRRs), calcium-binding S100 proteins (S100A8, S100A9), transglutaminase (TGM3), cytokeratins (KRT4, KRT13), gut-enriched Krupple-like factor (GKLF) and cystatin A. Interestingly, most of the downregulated genes encoded Ca(2+)-binding or -modulating proteins that constitute the cell envelope (CE). Moreover, genes associated with invasion or proliferation were upregulated, including genes such as fibronectin, secreted protein acidic and rich in cystein (SPARC), cathepsin B and KRT17. Functional analysis of the alteration in the expression of GKLF suggested that GKLF might be able to regulate the expression of SPRR1A, SPRR2A and KRT4 in ESCC. This study provides new insights into the role of squamous cell differentiation-associated genes in ESCC initiation and progression. 相似文献
994.
The lipid growth factor lysophosphatidic acid (LPA) is produced by ovarian cancer cells in quantities sufficient to attain concentrations of up to 10 microM. An autocrine circuit was demonstrated when ovarian cancer cells, but not normal ovarian surface epithelial cells, were proven to express LPA(2) (Edg-4) and LPA(3) (Edg-7) G protein-coupled receptors for LPA. Human LPA(2) now has been expressed transgenically in C57BL/6 mouse ovaries under direction of the alpha-inhibin large promoter. Human LPA(2) mRNA and protein were detected in all transgenic (TG) mouse ovaries at levels far higher than in other tissues and at least fivefold higher than in cultured lines of human ovarian cancer cells, with the expected sex cord-stromal distribution. Most LPA(2) TG ovaries produced significantly higher levels than non-TG ovaries of type A, but not type B, vascular endothelial growth factor (VEGF), isomers of VEGF-A, and urokinase-type plasminogen activator (uPA). Many LPA(2) TG ovaries had elevated expression of VEGF receptors 1 and 2, and a depressed level of type 2 PA inhibitor. Thus, the LPA-LPA(2) circuit regulates ovarian cells both directly and through increases in protein growth factor systems. 相似文献
995.
Kong DF Eisenstein EL Sketch MH Zidar JP Ryan TJ Harrington RA Newman MF Smith PK Mark DB Califf RM 《American heart journal》2004,147(3):449-456
Background
Drug-eluting intracoronary stents decrease restenosis and later revascularization. The US Department of Health and Human Services (HHS), recognizing the financial and clinical impact of this technology, recently proposed accelerated reimbursement to hospitals.Methods and results
A disease state-transition computer model simulated the clinical and economic consequences to hospitals of drug-eluting stents over 5 years. Model parameters combined information from a longitudinal clinical database, a hospital cost-accounting system, and a survey instrument. Simulations were repeated 1000 times for each set of parameters. With 85% of stent procedures shifted to drug-eluting stents in the first year of availability, the mean number of repeat revascularizations dropped by 60.4% at year 5. With no changes in reimbursement policy, a hospital with a catheterization laboratory volume of 3112 patients yearly converted from a $2.01 million (M) annual profit to an $8.10 M loss in the first year (95% CI $8.09 M to $8.12 M) and $8.7 M annual losses in later years. This represented an overall change in cash flow of $55.71 M (95% CI $55.66 M to $55.76 M) away from the hospital over 5 years. The incremental reimbursement proposed by HHS reduced this loss to $4.75 M in the first year and to $5.6 M annually thereafter. In sensitivity analyses, the conversion of patients from bypass surgery to drug-eluting stents was the largest driver of overall cash flow shifts.Conclusions
Although Medicare has proposed to increase reimbursement to ease the impact of drug-eluting stents on hospitals, this increase will not totally offset the costs. 相似文献996.
Pellissier JM Watson DJ Kong SX Straus WL 《Annals of internal medicine》2004,140(9):761; author reply 761-761; author reply 762
997.
Keratosis punctata palmoplantaris (KPPP) is a rare genodermatosis with an autosomal-dominant pattern of inheritance. We report the case of a 61-year-old woman who presented with a long history of multiple symptomatic hyperkeratotic papules on the palms and soles. In addition, we review the literature and present the current classification of the heterogeneous group of punctate palmoplantar keratoses, the cutaneous and histologic findings, the differential diagnosis, the possible association with various anomalies including malignancies, and the various treatment options. 相似文献
998.
Shi J Zhang S Ma C Liu X Li T Tang M Han H Guo Y Zhao J Zheng K Kong X Zhang K Su Z Zhao Z 《Acta neurologica Scandinavica》2004,109(2):140-145
OBJECTIVE: To investigate into the relationship of apolipoprotein CI (ApoCI) polymorphism with sporadic Alzheimer's disease (AD) in Chinese. SUBJECTS AND METHODS: A total of 257 AD patients and 242 age-matched elderly individuals were genotyped for the ApoCI HpaI and apolipoprotein E (ApoE) HhaI polymorphisms. RESULTS: The ApoCI A allele was associated with AD of moderate to severe dementia when patients were divided into two subgroups according to Clinical Dementia Rating scale, and the AA genotype was strongly associated with moderate to severe AD in ApoE epsilon4 allele carriers [odds ratio (OR) = 8.19, 95% confidential interval: 1.28-52.30, after adjusting for age and gender by logistic regression analysis], although in total no significant differences of allele or genotype frequency between patients and controls were found. CONCLUSION: The present study partially confirmed the previous findings, suggesting that the ApoCI A allele might contribute to the susceptibility to moderate to severe sporadic AD in Chinese. 相似文献
999.
Kwon YS Kim SS Sohn SJ Kong PJ Cheong IY Kim CM Chun W 《Archives of pharmacal research》2004,27(7):751-756
Flavonoids have been demonstrated to exhibit a wide range of biological activities including anti-inflammatory and neuroprotective
actions. Although a significant amount of flavonoids has been identified to be present as glycosides in medicinal plants,
determinations of the biological activities of flavonoids were mainly carried out with aglycones of flavonoids. Therefore,
the exact role of the glycosidation of flavonoid aglycones needs to be established. In an attempt to understand the possible
role of glycosidation on the modulation of the biological activities of flavonoids, diverse glycosides of kaempferol, quercetin,
and aromadendrin were examined in terms of their anti-inflammatory activity determined with the suppression of lipopolysaccharide
(LPS)-induced nitric oxide (NO) production in BV2 microglial cells. The results indicated that glycosidation of aglycones
attenuated the suppressive activity of aglycones on LPS-induced NO production. Although attenuated, some of glycosides, depending
on the position and degree of glycosidation, maintained the inhibitory capability of LPS-induced NO production. These findings
suggest that glycosidation of flavonoid aglycones should be considered as an important modulator of the biological activities
of flavonoids. 相似文献
1000.
Modulation of AP-1 by Natural Chemopreventive Compounds in Human Colon HT-29 Cancer Cell Line 总被引:11,自引:0,他引:11
PURPOSE: Activator protein-1 (AP-1) has been implicated as playing important roles in apoptosis and cancer development. In this work, we studied several natural chemopreventive compounds for their potential chemopreventive properties in the modulation of AP-1 signaling pathway in HT-29 colon cancer cells. METHODS: The HT-29 cells were transfected with AP-1-luciferase reporter gene, and one of the stable clones (C-4) was used for subsequent experiments. The HT-29 C-4 cells were treated for 1 h with various natural chemopreventive agents and challenged with AP-1 stimulators such as 12-O-tetradecanoylphorbol-13-acetate (TPA) or hydrogen peroxide (H2O2) for 6 h. The c-Jun N-terminal kinase (JNK) was examined to understand the effect of these compounds on the upstream signaling activator of AP-1. The protein expression level of endogenous cyclin D1, a gene that is under the control of AP-1, was also analyzed after treatments with the agents. In addition, cell death induced by these compounds was evaluated by MTS assay [3-(4.5-dimethylthiazol-2-yl)-5-(3-arboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt]. RESULTS: TPA and H2O2 treatments strongly induced AP-1-luciferase activity as expected. Phenethyl isothiocyanate, sulforaphane, curcumin, and resveratrol increased AP-1-luciferase activity dose-dependently and then decreased at higher doses in the presence or absence of TPA. Allyl isothiocyanate and (-)-epigallocatechin-3-gallate (EGCG) increased AP-1-luciferase activity dose-dependently up to 50 and 100 microM. Other tea catechins and procyanidin dimers, however, had little or no effect on AP-1-luciferase activity. The JNK activity was induced by the isothiocyanates and EGCG. Most of the chemopreventive compounds induced cell death in a dose-dependent manner, with the exception of epicatechin (EC) and the procyanidins, which had little effect. The expression of endogenous cyclin D1 protein was well correlated with those of AP-1-luciferase assay. CONCLUSION: Taken together, these results suggest that natural chemopreventive compounds may have differential biological functions on the signal transduction pathways such as AP-1 in the intervention of colon cancer progression and carcinogenesis. 相似文献